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Although the rhesus monkey (Macaca mulatta) was the first laboratory ani- 
mal found to be suitable for experimental work with the virus of yellow fever 
(1, 2), the laboratory mouse has also played an important rble in yellow fever 
research.  However, efforts to define more exactly the susceptibility of this 
animal have been few since the initial demonstration in 1930 that mice could 
be infected (3) and certain supplementary studies (4, 5) reported shortly there- 
after.  Basically, these early studies demonstrated the following: that adult 
mice are highly susceptible to virus inoculated by the intracerebral route (3, 
5) but can be infected regularly by extraneural routes only after the brain has 
been traumatized (4); that baby mice, in contrast, are highly susceptible to virus 
inoculated extraneurally (3); and that mice of several different strains are not 
equally  susceptible  (4,  5). 
Recently reported studies of the susceptibility of mice to yellow fever virus 
have been chiefly concerned with  the susceptibility of young mice to extra- 
neurally inoculated virus with special reference to the practicability of their 
use in protection tests (6) and in testing for the presence of small amounts of 
virus (7).  In studies now being terminated in this laboratory the exact rela- 
tion of age to the susceptibility of mice to several strains of virus, inoculated 
by extraneural routes, has been worked out (8), and it has been shown in addi- 
tion that significant differences related to age exist in the susceptibility of mice 
inoculated by the intracerebral route, the youngest mice being the most sus- 
ceptible to infection (9). 
The present paper reports observations indicating the occurrence of specific 
but  non-fatal  infections among  mice  inoculated  intracerebrally with  yellow 
fever virus.  A study has been made of the nature and course of such infections, 
and of the relation of their occurrence to the strain of virus employed and the 
dose  inoculated. 
Materials and Methods 
Strains of Yellow Fever Virus.--The observations to be reported were made in large 
part on mice inoculated with virus of the various  17D substrains  which have been 
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used as routine in Brazil in the preparation of yellow fever vaccine.  The evolution 
of the parent strain (17D) from Asibi by serial passage in tissue culture, and its maior 
characteristics, were first described in 1936 and 1937  (10,  11).  The substrains with 
which the present report deals are designated in the Rio de Janeiro laboratory as 
17DD  low,  17DD  high,  17D8, EP,  17D-NY  104,  and  17D-NY 310.  The detailed 
derivation and the individual characteristics of these substrains have been  described 
elsewhere (12-15). 
Observations have also been made on mice inoculated with the pantropic Asibi 
strain; with the mouse-fixed derivative of the French strain first developed by Theiler 
(3); and with a number of recently isolated strains of pantropic virus, most of which 
were recovered from human cases in early 1940 during an epidemic of jungle yellow 
fever in the State of Esplrito Santo, Brazil. 
Mice.--All of the mice used were of the Swiss strain, bred and raised in the colony 
of this laboratory from stock imported from a New York breeder 2 and 4 years ago. 
Mice of exactly known but different ages were used, chiefly within the range of from 
21 to 55 days. 
Virus Titratlons.---Quantitative  determinations of virus activity were based upon 
the intracerebral inoculation of serial fourfold or decimal dilutions of the preparation 
being studied, into groups of mice, the number of which varied with the experiments. 
As diluent, human or monkey serum,  demonstrated by means of careful protection 
test studies to possess no virus-neutralizing activity, was employed in l0 per cent con- 
centration in physiological saline.  In the intracerebral inoculation of the mice the 
site (midfrontal area) and depth of inoculation (2 mm.) were carefully controlled to 
insure the greatest possible uniformity and sensitivity of virus detection. 
Inoculated mice were kept regularly for 21  days after inoculation during which 
time the occurrence of signs of specific infection, fatal or otherwise, was noted.  In 
the normal routine, the titer was then calculated by the 50 per cent end-point method 
(16) on the basis of the number of mice dying during the period of observation. 
Prolonged Observation of Mice.--A large number of mice were collected which had 
manifested signs suggestive of illness following inoculation with 17D virus but which 
were still alive 22  days later.  Immediately as collected, such mice were carefully 
examined and classified as to their condition according to the following scheme. 
Normal.--A small number of mice had apparently recovered completely from their 
obvious illness by the 22nd post-inoculation day. 
WeaL--Mice in this category showed an impaired ability to resist backward trac- 
tion across a wire grating, although no definite paralysis could be detected. 
Slight Paralysis.--Mice  so classified had clearly localized but incomplete paralysis 
of one or more extremities. 
Marked Paralysis.--Such  mice showed complete, flaccid paralysis of one or more 
extremities. 
Spastic.--Mice considered in this group had developed a  spastic paralysis of one 
or more extremities.  Most commonly, both hind legs were affected, and the condi- 
tion was associated with the loss of sphincter control. 
Sick.--A small number of mice showed the signs often seen at the onset of apparent 
encephalitis, ruffled fur, a  hunched position, reduced activity, but failed to develop 
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AtypicaL--Mice  dassified  as  atypical  presented  such  signs  as  marked  hyper- 
reactivity, weakness  associated  with  marked  tremors  or restlessness,  and  atypical 
ruffling of the fur.  Although often thought not to represent examples of yellow fever 
encephalitis, they could not be excluded with certainty. 
As the mice were accumulated  and classified, they were formed into groups  and 
individually  marked with picric acid and gentian  violet for future identification.  As 
necessary,  these  markings  were  renewed.  The  mice  were examined  subsequently 
two times a week in order to record any changes in their state, and at various intervals 
were  sacrificed  for  special studies.  Occasionally,  this  prolonged  observation  was 
terminated involuntarily  by the appearance  of mouse typhoid, which necessitated the 
immediate disposal of the affected groups. 
Detection of Serum Antibody.--At  desired intervals  mice were exsanguinated  from 
the heart to obtain serum for study; from 0.5 to 1.0 ml. of blood was obtained  from 
each animal.  In most cases the blood specimens from several mice were pooled before 
the serum was separated,  although specimens adequate for testing were obtained from 
a number of individuals.  All examinations of sera were made by the intraperitoneal 
protection  test technique in which young mice, in the present case 19 days of age, are 
employed, and which requires no more than 0.4 ml. of serum  (6). 
Non-Fatal Infections  with 17D Virus 
In the course of the many titrations necessary to the careful control of the 
virus content of  individual lots of 17D vaccine, it was noted that not a  few 
mice which had developed typical signs of encephalitis were still alive at the 
close of the usual 21 day observation period.  The  study of the eventual fate 
of such mice and of the  true nature of their disease  constituted  the starting 
point for the present investigations. 
Manifest Infections 
Material for the initial  studies was obtained by collecting over a  period of 
several  months  all  mice  employed  in  routine  vaccine  titrations  which  had 
shown signs of illness  at any time and which were still alive on the 22nd day 
after inoculation.  In all,  543  mice were collected.  Examined and classified 
according to their clinical condition following the criteria indicated in Materials 
and Methods,  these  mice were  held  under  observation for varying  intervals 
until sacrificed for special studies. 
Course of the Disease.--As long as they remained under observation the mice 
were examined twice weekly to record the course of their disease.  The scope 
of this study is indicated in Table I  which shows at succeeding intervals post- 
inoculation the number of mice which were under observation, which died as 
the  result  of encephalitis  or of mouse typhoid,  and  which were  deliberately 
sacrificed. 
It is evident from this table that death, due either to the progression of the 
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suiting from initial attack, played only a  small r61e in bringing the period of 
observation to a  close.  Such deaths occurred with greatest frequency before 
dae 31st day post-inoculation,  and,  although not indicated  in the table, were 
largely among mice which first became ill near the close of the routine observa- 
tion period.  Mice which manifested the first signs of encephalitis before the 
15th day post-inoculation and were still alive on the 21st day usually could be 
kept alive for an indefinite period.  At the time the study was terminated 50 
mice had been observed for at least 100 days, 10 of these not being sacrificed 
until  the  114th  day. 
The results of the initial and subsequent examinations are briefly summarized 
in Table II, both to show the initial distribution of the mice among the several 
TABLE  I 
Continued Observation (beyond the 21st Post-Inoculation Day) of Mice Infected u4th 17D Virus 
Number under Observation, Dying, or Sacrificed during Successive Intervals after Inoculation 
22-25 
No.  of  mice under  obser- 
vation ..................  543 
Deaths  due  to  No  ....... 
specific  dis-  Per cent.. 
ease 
Deaths  due  to  No ........  0 
mouse  ty-  Percent..  0 
phoid 
No. of mice sacrificed  .......  21 
Interval post-inoculation (days) 
41 
7.6 
26-30 
¢81 
10 
2.8 
11 
31-35  36-40 
460  !433 
5  3 
1.1i  0.7 
2  0 
0.4  0 
20  36 
41-50  51-60 ' 
394  276 
4  0 
1.0  0 
7  15 
1.8  5.4 
107  151 
61-70 
110 
15 
13.6 
22 
71-80 
73 
1 
1.4 
2 
2.7 
81-100 
63 
1 
1.6 
12 
i00-Ii~ 
50 
1 
2.C 
5 
10 .( 
44 
categories already defined, and to illustrate the changes which occurred in the 
state of the animals during  the period of observation, the length of which,  it 
must be remembered, varied greatly.  Further progress of the disease occurred 
in 92 cases (16.9 per cent), including in this total the 66 deaths believed to have 
been due, directly or indirectly, to the encephalitis.  In contrast, obvious im- 
provement, at times to the point of complete recovery, was observed in  155 
mice (28.6 per cent).  As the table indicates, such improvement was relatively 
much more frequent in those mice which had experienced the milder manifes- 
tations of the disease, such as weakness, or only slight paralysis, the improve- 
ment rates in these two categories being 55.7  and 51.2 per cent, respectively. 
Histopathological Examination.--Twenty  mice  were  sacrificed  at  intervals 
of from 24  to  114  days post-inoculation  to provide material for histological 
examination.  The brains of these mice were fixed in formalin,  embedded in 
paraffin, and sectioned.  The sections were stained with hematoxylin and eosin. 30~N  P.  FOX  511 
At 24 days signs of a  still active process were present,  including small areas 
of hemorrhage and degeneration of the nerve cells.  At 31  days perivascular 
cuffing and lymphocytic infiltration of the meninges were still prominent,  the 
cerebral capillaries seemed engorged, and a  glial reaction was evident, but de- 
generating  nerve  cells  were hard  to find.  At  38  and  50  days,  perivascular 
cuffing  and  the  meningeal  infiltration  were  decreased  but  present,  and  foci 
of glial  cells were  easily  seen.  After  the  85th  day no  cuffing of the vessels 
could  be  detected,  and  the  sections  examined  appeared  essentially  normal. 
The histological studies,  thus, confirmed the impression gained during life that 
in most cases little progression of the essential disease process occurred beyond 
the  normal  21  day observation period. 
TABLE II 
Summary of the Changes in the Clinical State of Mice Surviving 17D Virus Encephalitis 
Clinical condition  on 22nd 
day post-inoculation 
Kormal.. 
~Veak  ..... 
~light paralysis... 
Harked paralysis. 
]pastic. 
~ick. 
~typical. 
Totals. 
No. of  Disease  progressed  mice 
7 
113 
86 
229 
84 
13 
11 
543 
Subsequent clinical course 
No. of 
mice  Per cent 
1  14.3 
12  10.6 
15  17.4 
41  17.9 
12  14.3 
10  76.9 
1  9.1 
92  16.9 
Condition unchanged 
No. of  Per cent 
mice 
6  85.7 
38  33.6 
27  31.4 
148  64.7 
70  83.3 
0  0 
7  63.7 
296  54.5 
Condition improved 
No. of  Per cent 
mice 
0  0 
63  55.7 
44  51.2 
40  17.4 
2  2.4 
3  23.1 
3  27.3 
155  ]  28.6 
Virus Isolation from the Brains.--Since the mice under study had been inocu- 
lated with yellow fever virus of the  17D  strain,  strong presumptive  evidence 
existed  as  to  the  etiology of  the  disease  observed.  It  remained  necessary, 
however,  to exclude the participation of some virus endemic  in mice, such as 
that  of spontaneous mouse encephalomyelitis  (17). 
Initial studies were carried out on mice which had shown signs of illness for 
from 1 to 11 days.  Brains taken during the first 2 days from such mice, pre- 
pared  as  a  10  per  cent  suspension  in  saline  and  inoculated  in  serial  decimal 
dilutions  into  new  mice,  were  found  to  contain  an  infectious  agent  demon- 
strable in dilutions of 10  -5 or 10  -~.  Brains taken from the 3rd to the 5th day 
were found to be infectious irregularly and only in low dilutions, while brains 
taken  after  the  5th  day were not  infectious  at  all.  Although  the  infectious 
agent  was  not  specifically  identified,  its  behavior was  typical for  17D virus. 
Furthermore, pooled sera obtained from the same mice were found in all cases 
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In subsequent studies, the brains of 35 additional mice, sacrificed on from the 
14th to the 28th day of illness, were examined.  These mice included 14 classi- 
fied as weak, 3 with marked but flaccid paralysis, and 18 which were spastically 
paralyzed.  Material from each brain, suspended in 10 per cent concentration 
in saline was inoculated into 6 mice which were observed for 6 weeks.  In no 
case was an infectious agent demonstrated. 
Serological  Immunity.--The  disease  process  in  mice  which  were  classified 
as normal or only weak on the 22nd day post-inoculation was considered to be 
of particularly uncertain etiology, and a special effort was made to secure serum 
samples which were adequate for examination from individual animals in these 
groups.  Twelve specimens were obtained,  all of which gave clearly positive 
results in the protection test. 
TABLE III 
Serum A ntibody Levels in Surviving, Intracerebrally Infected Mice at Varying Intervals Following 
Inoculation 
Titers of serum pools collected  during post-inoculation  intervals of: (days) 
Protection  test 
Run 1 .......... 
Run  2 .......... 
22-25  26-30  31-35  3640  41-50  51-60  61-70  71-80  81-100  100-114 
21°121°1  17°]  128  12s61  158  [  I 
128  74 
126  38  98  136  81  132  182  39  47 
Studies also were made on serum pools obtained from a much larger number 
of mice and representing all categories of obvious disease.  These pools, each 
containing sera of from 4 to 8 animals, were titrated in two runs of the protec- 
tion  test,  using  12  test mice per fourfold dilution  of serum.  The  titers ob- 
tained are shown in Table III with relation to the approximate interval post- 
inoculation  in  which  the  sera  were  collected.  It is  evident  that  protective 
antibodies against yellow fever virus were present in the sera in clearly signifi- 
cant  concentrations  up  to  114  days post-inoculation,  when  the  observations 
were terminated. 
Resistance  to  Reinfection.--Although  the  serological  studies  had  indicated 
that immunity against yellow fever virus was the rule among mice surviving 
apparent infection with  17D virus,  the immune state of individual mice was 
verified in a limited number of cases only.  In order to multiply the number of 
observations on individual  mice,  tests of their  resistance  to reinfection with 
virulent French neurotropic virus were employed. 
Of the 240 mice which were inoculated intracerebrally with challenge doses 
of from 10  e to 107 M.L.D. of virulent virus, only 22  failed to survive.  Twelve 
of the deaths occurred among mice in which  the original diagnosis was most JOHN 1".  FOX  513 
open to question, nine being among a group of 49 mice originally classed as weak, 
and three being among a group of 5 classed as atypical.  Although 9 of 112 mice 
with marked paralysis also died following the challenge inoculation, death in 
8 of these cases was of uncertain cause as it was preceded by atypical signs, 
by no signs at all, or by evidence suggesting mouse typhoid.  The remaining 
non-resistant mouse was one of 37 animals showing only slight paralysis.  Of 6 
apparently normal mice and of 31 spastic mice, all successfully withstood the 
challenge. 
Since the great majority of mice (over 90 per cent) surviving an apparent 
infection following inoculation with material containing 17D virus are resistant 
to subsequent infection with virulent yellow fever virus, it is at least strongly 
suggested that their resistance was the direct result of their prior infection, and 
that the etiological agent of the prior infection was yellow fever virus of the 
17D strain. 
Inapparent Infections 
The clinically apparent but non-fatal disease which presumably resulted from 
infection with 17D virus varied in severity from an illness resulting in marked 
and permanent impairment of function to one of but briefly transient nature. 
That still milder and completely inapparent infections also might occur was 
an obvious possibility. 
Preliminary  experiments  carried  out  on  apparently  normal  survivors  of 
titrations of 17D virus soon revealed that a  small but significant number of 
mice were resistant  to cerebral infection with highly virulent French neuro- 
tropic virus.  The absolute  regularity with which  normal mice of the  same 
stock succumb to the doses of French neurotropic virus which were employed 
(10  s to  104 M.L.D,) precludes the possibility that  the resistance observed was 
due in an appreciable number of cases to natural resistance of individual mice. 
Serological  studies  were  also  carried  out.  Apparently  normal  survivors 
from titration groups in which at least one mouse had succumbed with specific 
encephalitis were sacrificed by bleeding, and the sera obtained from each group 
were pooled.  These pools, each of which contained the sera of from 2  to 4 
mice,  were  then examined by means  of  the protection test.  Of  twenty-six 
pools examined, three were found to contain clearly demonstrable protective 
antibodies against yellow fever.  These serological observations testify to the 
specific immune basis  of the  occasional resistance to infection with virulent 
virus offered by apparently normal survivors of 17D virus titrations, and make 
it evident that with yellow fever virus of this strain, at least, completely in- 
apparent infection of mice may occur. 
The Frequency of Non-Fatal Infections with 17D Virus 
The foregoing observations have been based upon a relatively large number 
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remain for consideration the possible relation of the  occurrence of non-fatal 
infections to the amount and the substrain of the 17D virus inoculated,  and 
also  the  importance  of such  infections  to  the  quantitative  determination of 
virus activity. 
Relation  of Non-Fatal Infections  to  Virus  Dose.--To  determine the relation 
of the occurrence of non-fatal infections to the dose of virus inoculated,  the 
results of 141 routine titrations of 17D virus were reviewed.  These titrations, 
using 12  (or rarely,  6)  mice per fourfold dilution,  were selected so that none 
contained less  than four infective dilutions.  Since none of the mice had been 
subjected to challenge inocula, the tabulations were limited to the enumeration 
of animals surviving clinically evident infections. 
TABLE IV 
Occurrence of Non-Fatal Infections* in Mice in Relation to Quantity of 17D Virus (Substrains 
17DD Low and EP  Inoculated 
M.L.D.~ of virus  No. of mice  No. of fatal  Non-fatal infections 
inoculated  infections  No.  Mice inoculated  Mice  infected 
0.1-  0.9 
1.0-  3.9 
4.0-  15.9 
16.0-  63.9 
64.0-255.9 
256 or more 
Totals.. 
inoculated 
2,336 
1,585 
1,525 
1,276 
1,029 
138 
7,889 
463 
1,038 
1,324 
1,197 
1,012 
136 
5,170 
35 
41 
58 
41 
10 
1 
186 
pe~ ce~ 
1.50 
2.59 
3.80 
3.21 
0.97 
0.73 
2.36 
per ceng 
7.03 
3.80 
4.19 
3.31 
0.98 
0.73 
3.48 
* Tabulation limited to clinically evident infections.  (See  text.) 
:~ Minimum lethal dose as determined in the fitrations in which these mice were used. 
As summarized in Table IV, this review demonstrated conclusively that non- 
fatal infections, at least  those evident during life,  occur more frequently fol- 
lowing the inoculation of small doses of virus.  With inocula containing less 
than 1 ~r.L.D., 7.03 per cent of the infected mice survived; when between 1 and 
63.9 ~.L.D. were inoculated, from 3 to 4 per cent survived; and finally, of ani- 
mals infected with 64 M.L.D. or more, less than 1 per cent survived. 
Relation of Non-Fatal Infections  to  Virus Substrain.--The  17D virus of the 
141 routine titrations referred to in the previous section represented but two 
substrains.  Much  more  suitable  data  for  determining  the  relation  of  non- 
fatal infection to 17D substrain were provided by the results of two experiments 
in each of which were titrated, under strictly comparable conditions, a number 
of preparations representing different substrains of virus.  In the first experi- 
ment, four substrains were studied,  using 24 mice (35  to 42 days of age) per 
tenfold dilution of each preparation.  In the second, preparations representing JOHN P.  Fox  515 
six different substrains were titrated on a  much larger scale,  102  mice (50 to 
52  days of age) being inoculated per fourfold dilution.  Within  each experi- 
ment, the range of infective dilutions  examined in mice was very nearly  the 
same for the various substrain preparations.  In both experiments,  all  mice 
which were still alive on the 28th day after inoculation received an intracerebral 
challenge inoculum of from 103 to 10  * ~.LD. of French neurotropic  virus. 
The results of these two experiments are summarized for present purposes 
in Table V in which the six substrains studied have been listed in the order of 
TABLE V 
Occurrence of Non-Fatal Infections in Mice in Relation  to Substrain of 17D Virus 
Virus substrain 
17DD low 
17D~ 
EP 
17DD high 
17D-NY 310 
17D-NY 104 
~x 
m 
m 
1 
2 
1 
2 
1 
2 
2 
2 
1 
2 
talC( 
118 
605 
118 
596 
119 
595 
6O8 
607 
118 
607 
[  No. of 
fatal 
ted  infections 
85 
325 
91 
282 
99 
304 
328 
387 
94 
4O0 
Non-fatal infections 
No.  No. in- 
apparent*  apparenU; 
4  2 
17  3 
2  2 
8  10 
1  2 
10  1 
7  3 
2  4 
o  i  o 
1  0 
Total 
No. 
6 
20 
4 
18 
3 
11 
10 
6 
0 
1 
All 
infections 
per cent 
6.6 
5.8 
4.2 
6.0 
2.9 
3.5 
3.0 
1.5 
0.0 
0.2 
* Apparent infections: paralyzed and resistant to reinoculation. 
Inapparent infections: no evidence of disease but resistant to reinoculafion. 
decreasing frequency of non-fatal infections.  The results of both experiments 
are in  essential agreement and  indicate  that  the  occurrence of non-fatal in- 
fections,  apparent  and  inapparent  combined,  is  significantly  related  to  the 
substrain  of virus  employed.  Of 495  mice infected with  virus of  substrain 
17D-NY 104,  all but 1 succumbed; whereas, of 436 mice infected with 17DD 
low virus, 26 (or 6 per cent) survived. 
Table V also gives some indication of the comparative frequency of apparent 
and inapparent infections.  Of the total of 79 non-fatal infections verified by 
the demonstration  of resistance  to reinfection,  27  had  produced  no  manifes- 
tations during life.  It probably is also of significance that an unusually high 
proportion of these inapparent infections were produced by virus of substrain 
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Significance of Non-Fatal  Infections  to Quantitative Determinations of Virus 
Activity.--It is evident that, in so far as virus of a particular substrain produces 
non-fatal infections in mice, quantitative determinations of its activity based 
only on mice dying are not fully accurate.  For this reason, it has become the 
practice in  this  laboratory to  administer  intracerebral doses of from  103  to 
104 M.L.D. of French neurotropic virus to all mice surviving the usual observa- 
tion period in those titrations in which full accuracy is of special inportance. 
Mice resisting such challenge doses are presumed to have been infected by the 
virus contained in the original preparation titrated, and are included with those 
whose infection resulted in a  fatal encephalitis in the calculation of the titer. 
The increase  in  the  accuracy of the  titers  so  obtained varies directly,  of 
course, with the proportion of non-fatal infections produced.  Obviously, with 
virus of substrain 17D-NY 104 the application of the reinoculation technique 
is of no importance.  On the other hand, with virus of substrains  17DD low 
and  17D3 its application may result in a  25 per cent increase in the level of 
infectivity detected. 
Observations with Other Strains of Yellow Fever Virus 
Observations with  strains  of yellow fever virus  other than  17D  were less 
extensive since work with these has been conducted on a much smaller scale. 
In the case of the French neurotropic strain (of from the 500th to 600th pas- 
sage in mice) and the pantropic Asibi strain (long maintained by serial passage 
in rhesus monkeys), mice showing grossly detectable signs of illness have not 
been  observed to  survive.  However, a  few silent  infections apparently  do 
occur, as is indicated by the fact that occasional mice surviving titrations of 
virus of these two strains resist reinfection, and also by the fact that pools of 
sera from such mice have been found to contain protective antibodies.  Al- 
though the available data do not permit an accurate estimate,  it is probable 
that inapparent infections with these two strains are too infrequent to be of 
quantitative importance. 
Freshly isolated strains from Brazilian cases of jungle yellow fever, however, 
present quite a  different picture.  As the result of experience with the more 
than 100 jungle strains that have been isolated up to the present time, workers 
in Brazil have long recognized that  the susceptibility of mice to unmodified 
virus  of jungle  origin  may  not  be  uniform.  Freshly  obtained  serum  from 
yellow fever patients has often been observed, when inoculated into mice, to 
give rise to a mild disease from which the animals recover completely if given 
the opportunity.  In such cases, attempts to initiate passages often were de- 
layed in the expectation that the next day or few days would find the suspect 
mouse more certainly sick, with the result that, when passage was finally at- 
tempted, no virus could be recovered. 
In Table VI are recorded observations made on mice inoculated with virus jom~  v.  Fox  517 
of  seven  strains  isolated  from  patients  early  in  1940  during  an  outbreak  of 
jungle  yellow  fever  in  the  State  of  Espirito  Santo,  Brazil.  The  inocula  con- 
sisted  of  serum  freshly  obtained  from  the  actual  patients,  or  material,  serum 
TABLE  VI 
Occurrence of Non-Fatal Infections in Mice Inoculated  with Virus Freshly Isolated from Cases of 
Jungle Yellow Fever 
Virus 
strain* 
AC 
JVC 
FM 
OC 
AF 
MOF 
MP 
Source of  mouse inoculum 
(0.03  ml.) 
HUMAN serum 
Monkey  " 
tc  t~ 
Mouse brain 
Monkey serum 
Mouse brain 
Monkey serum 
Human serum 
Monkey  " 
Mouse brain 
Monkey serum 
Monkey serum 
Mouse brain 
Monkey serum 
No. of mice  No. of fatal 
inoculated  infections 
Study ofsurvivingmice 
ReinoculatioM:  Protection  test 
No.  No.  No. of  PR§ of  sera  resisting  dying  pooled  pool 
4  2  0  2  --  -- 
4  1  3  0  --  -- 
6  5  1  0  --  -- 
6  2  4  0  --  -- 
6  5  --  --  1  6/6 
6  5  0  1  --  -- 
8  7  1  0  --  -- 
6  5  1  0  --  -- 
6  3  3  0  --  -- 
6  5  1  0  --  -- 
6  1  --  --  5  6/6 
6  5  1  0  --  -- 
6  4  2  0  2  2/6 
6  2  --  --  i  2  0/6 
6  4  --  --  ]  2  0/6 
6  4  --  --  !  2  6/6 
6  2  --  --  4  6/6 
* Initials refer to patients from whom virus was isolated. 
:~ Reinoculation with 100 ~.LD.  of French neurotropie virus, a  dose which killed 30 of 31 
control mice. 
§ PR: protection ratio or number of mice protected versus number employed in test. 
or brain,  from  monkeys  and  mice  of the  first or second  virus  passages.  Mice 
surviving  the usual  period  of observation,  many  of which  had  shown  transient 
signs of illness,  were  tested  either  by  cerebral  inoculation  with  French  neuro- 
tropic  virus  or by  examination  of their  pooled  sera in the  protection  test.  Of 
20  mice  given  a  challenge  inoculation,  17  resisted  reinfection;  while  of  seven 
serum  pools examined,  each representing  from  1  to 4  mice, four showed  clearly 518  YELLOW  FEVER  VIRUS  IN  MICE 
demonstrable  protective  power,  one  yielded inconclusive  results  (probably 
weakly positive),  and two were entirely negative.  It thus seems clear that a 
high proportion of mice inoculated with virus of these jungle strains may de- 
velop a  non-fatal but  immunizing  infection. 
This frequent survival of infected mice led to considerable difficulty in titra- 
tions which were necessary in  the  course  of studies  on animal  susceptibility 
and insect transmission with virus of these jungle strains.  This difficulty was 
TABLE VII 
Titrations of Jungle  Yellow Fever Virus in Mice 
Importance of Considering Non-Fatal Infections 
Stra 
jz 
JZ 
OC 
Virus  No. of mice  Titers as based on 
Infected 
Preparation 
Monkey serum 
Monkey serum 
Triturated 
mouse brain 
Dilution 
I0-* 
10-2 
10-3 
10-4 
10-1 
10-2 
I0-3 
10-4 
lO-I 
10-2 
10-3 
10-4 
Inocu- 
lated 
12 
12 
12 
12 
12 
12 
11 
12 
11 
10 
12 
12 
Fatally  Total~t 
4  11 
4  8 
5  10 
4  4 
4  12 
8  11 
0  0 
0  0 
8  11 
8  10 
5  6 
2  2 
Not 
infected 
0 
1 
11 
12 
0 
0 
6 
10 
Deaths 
Deaths  plus 
only  non-fatal 
infections 
60.3  2340 
31.6  288 
28.2  1410 
* JZ: isolated in Matto Grosso in 1937. 
OC: isolated in Esplrito Santo in 1940. 
:~ Includes non-fatal  infections revealed by resistance  to an intracerebral  challenge with 
French neurotropic virus. 
largely overcome by the application of the reinoculation technique,  as is indi- 
cated in Table VII in which are presented the results of three typical titrations. 
The results, in terms of fatal infections only, failed completely to indicate sharp 
end-points.  However,  when  corrected  to include as well  the non-fatal infec- 
tions revealed by reinoculating the surviving mice with neurotropic virus,  the 
results indicated not only adequately sharp end-points but also infective titers 
of from 9  to  nearly  40  times  those  based  on fatal  infections  alone.  These 
examples well illustrate that the reinoculation technique is absolutely necessary 
to quantitative  work with virus of these jungle strains. JOHN P.  FOX  519 
DISCUSSION  AND  SUMMARY 
Observations have been reported which indicate that mice inoculated  intrao 
cerebrally with active yellow fever virus may develop an infection which is not 
only non-fatal but may also be completely inapparent. 
The most extensive observations were made on mice which showed  signs 
of infection but were still alive 22 days after inoculation with virus of one or 
another of several 17D  substrains.  In such cases,  the infection usually pro- 
gressed no further and partial  or  complete recovery often  ensued.  Agents 
other than yellow fever virus were excluded as a significant cause of such non- 
fatal infections by the failure of repeated attempts  to isolate other infective 
agents,  by the demonstration of antibodies against yellow fever virus in the 
sera of the mice, and by the demonstration of a  high degree of resistance on 
the part  of such surviving mice to reinoculation with large doses of neuro- 
tropic yellow fever virus. 
Completely inapparent infections with 17D virus were also shown to occur. 
Studies of apparently normal survivors of 17D virus titrations revealed a small 
but  signifcant  number  of animals  resistant  to  intracerebrat  challenge with 
neurotropic yellow fever virus.  Further,  pooled  sera  from such  mice  were 
shown to contain specific protective antibodies. 
The occurrence of non-fatal infections with 17D virus was found related to 
virus dose and substrain.  Small doses of virus provoked a significantly higher 
proportion  of non-fatal  infections  than large doses; while different 17D  sub- 
strains, tested over equivalent ranges of virus dose, varied greatly with respect 
to the proportion of infections which did not terminate with death.  In the case 
of two substrains  (17DD low and  17D3), non-fatal infections (as demonstrated 
by resistance to intracerebral challenge with neurotropic virus) were sufficiently 
frequent to cause an increase, when included in the computation of the infective 
titers, of 25 per cent above the figures based on deaths alone.  The demonstra- 
tion of non-fatal infections, thus, may be important to the accuracy of quanti- 
tative determinations of infectivity. 
Limited observations with virus of the French neurotropic and the pantropic 
Asibi strains revealed that non-fatal infections do occur, but only rarely. 
Somewhat  more  extensive  observations  with  unmodified  virus  of  strains 
isolated from Brazilian cases of jungle yellow fever, in contrast, revealed an 
occurrence of non-fatal infections much greater than that observed with the 
most productive 17D  substrains.  With  these jungle strains,  the demonstra- 
tion of non-fatal infections proved indispensable to any measure of the level 
of infectivity of virus preparations. 
The demonstration of the proportional occurrence in mice of non-fatal in- 
fections with yellow fever virus provides an additional means by which differ- 
ent virus strains and substrains may be characterized. 520  YELLOW FEVER VIRUS IN MICE 
BIBLIOGRAPHY 
1.  Stokes, A., Bauer, J. H., and Hudson, N. P., J. Am. Meg. Assn., 1928, 90, 253. 
2.  Stokes, A., Bauer, J. H., and Hudson, N. P., Am. J. Trop. Meg., 1928, 8~ 103. 
3.  Theiler, M., Ann. Trop. Meg. and Parasitol., 1930, 24~ 249. 
4.  Sawyer, W. A., and Lloyd, W., J. Exp. Meg., 1931, 54p 533. 
5.  Theiler,  M., Ann. Trop. Meg. and Parasitol., 1933, 27~ 57. 
6.  Whitman, L., AnL J. Trop. Meg., 1943, 23~ 17. 
7.  Bugher, J. C., Am. J. Trop. Meg., 1941, 21, 299. 
8.  Waddell, M. B., unpublished data. 
9.  Fox, J. P., unpublished data. 
10. Lloyd, W., Theiler,  M., and Ricci,  N. I.,  Tr. Roy. Soc. Trop. Meg. and Hyg., 
1936, 29~ 481. 
11. Theiler,  M., and Smith, H. H., J. Exp. Meg., 1937, 65, 767. 
12. Fox, J. P., and Penna, H. A., Am. J. Hyg., in press. 
13.  Soper, F. L., Smith, H. H., and Penna, H. A., Proc. 3rdlnternat.  Cong. Microbiol., 
New York,  1939, 351. 
14.  Fox, J. P., Lennette, E. H., Manso, C., and Souza Aguiar,  J. R., Am. J. Hyg., 
1942, 86~ 117. 
15. Fox, J. P., and Cabral, A. S., Am. J. Hyg., 1943, 871 93. 
16. Reed, L. 3, and Muench, H., Am. J. Hyg., 1938, 27, 493. 
17. Theiler,  M., J. Exp. Meg.,  1937, 65, 705. 